Reduction in CD11c+ microglia correlates with clinical progression in chronic experimental autoimmune demyelination
Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease with high variability of clinical symptoms. In most cases MS appears as a relapsing-remitting disease course that at a later stage transitions into irreversible progressive decline of neurologic function. The mechanisms underlying...
Guardado en:
Autores principales: | Florian Mayrhofer, Zhanna Dariychuk, Anthony Zhen, Daniel J. Daugherty, Peter Bannerman, Angela M. Hanson, David Pleasure, Athena Soulika, Wenbin Deng, Olga V. Chechneva |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/302d5ae29ee14ef795820b683ac8af09 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The oligodendrocyte-enriched orphan G protein-coupled receptor Gpr62 is dispensable for central nervous system myelination
por: Curtis M. Hay, et al.
Publicado: (2021) -
BASHY Dye Platform Enables the Fluorescence Bioimaging of Myelin Debris Phagocytosis by Microglia during Demyelination
por: Maria V. Pinto, et al.
Publicado: (2021) -
Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Qinqin Wang, et al.
Publicado: (2021) -
BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis
por: Kang,Youra, et al.
Publicado: (2017) -
Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
por: Ghareghani Majid, et al.
Publicado: (2021)